Bismuth is a chemical element with the symbol Bi and atomic number 83. It is a pentavalent metal which chemically resembles Arsenic (As) and Antimony (Sb). Bismuth salts, especially colloidal bismuth subcitrate (CBS) and bismuth subsalicylate, are widely used to treat peptic ulcers, functional dyspepsia, and chronic gastritis.Bismuth and most of its compounds are less toxic in comparison to other heavy metals like lead, antimony, cadmium, etc. The main organs involved in bismuth poisoning are kidney, liver and bladder. Skin and respiratory irritation can also follow exposure to respective organs. Large concentration of bismuth is contained in kidney and is primarily excreted through this organ while lesser amounts of bismuth are excreted via saliva, milk and bile. Routes of exposure are skin/eye contact, inhalation and ingestion. The toxic results developed by this heavy metal are serious ulcerative stomatitis, vague feeling of bodily discomfort, nausea, vomiting, loss of appetite and weight, pain in legs, arms and joints, depression and sleeplessness, pyorrhea and exodermatitis. Management of the bismuth poisoning is done in the same line as any other heavy metals, with irrigation of the stomach (gastric lavage) and chelating agents.
ranitidine bismuth subcitrate, bismuth subcarbonate, bismuth subnitrate, and bismuth subgallate. Some preliminary evidence suggests that bismuth carbomer enemas may reduce pouchitisthat may occur after colonal removal. Bismuth subgallate has been studied for controlling odor after an ileostomy which is a hole surgically constructed in the abdomen to eliminate waste and bismuth subnitrate has been used for treatment of dyspepsia and bismuth subnitrate has been used for treatment of Helicobacter pylori infection. The reported toxic effects caused by overdose of bismuth compounds include encephalopathy, nephropathy, osteoarthropathy, gingivostomatitis, and colitis.Bismuth poisoning mostly affects the kidney, liver, and bladder. Chronic exposure to high levels of bismuth salts result in encephalopathy, whereas acute toxicity manifests as nephrotoxicity. [1] [2] [3] [4] [5] [6] 
SOURCES OF BISMUTH
Common sources of Bismuth are as follows:
• About 0.02 µg/litre Bi is present in Sea water.
• In natural water, concentrations of Bismuth are found to be very low, usually less than 0.2 µg/litre. • Anthropogenic sources of bismuth include copper, lead, silver and gold smelting, waste water and sewage sludge.
• In elemental abundance Bismuth ranks 69 th in the Earth's crust and is considered almost two times as abundant as gold.
• Pure bismuth can also be obtained by reducing the oxide with carbon or by roasting the sulfide in the presence of charcoal and metallic iron to remove the sulfur.
• The most common mineral ores are Bismuthinite (Bi2S3) and Bismite (α-Bi2O3).
• The Tasna mine in Bolivia has the largest bismuth deposits and one mine in China.
These are the only mines that have produced bismuth from a bismuth ore.
• As production of bismuth is a byproduct of processing lead ores, world reserves of bismuth are usually based on bismuth content of lead ores.
• In some nuclear reactors, Lead-Bismuth Eutectic (LBE) alloys which contain 44.5% lead and 55.5% bismuth are used as a coolant.
• Bismuth has been used traditionally for stomach problems. Bismuth subgallate has been used for controlling odor after an ileostomy which is a surgical opening in the belly wall to allow waste to be removed.
• It is used in the manufacture of cosmetics and pharmaceuticals, ceramic glazes, pearlescent pigments, permanent magnets and safety devices in fire detection and extinguishing systems.
• Bismuth can also be used in the electronics industry and in the production of catalysers, steel, aluminium and fusible alloys.
• Addition of bismuth subnitrate to other medications such as antibiotics, may improve the elimination of bacteria over the medications alone.
• Bismuth has been established as a safe and well-tolerated treatment for Helicobacter pylori infections in adults and children.
• Bismuth subnitrate reduces the acidity of the stomach, as well as increase the production of a substance which improves healing of ulcers.
• Bismuth carbomer enemas have been used for chronic pouchitis (inflammation of a surgically constructed bowel pouch) and bismuth subgallate for tonsillectomy (removal of tonsil).
• Bismuth subnitrate, ginseng, and tang-kuei ten may reduce kidney dysfunction associated with cisplatin treatment, although conflicting results exist.
EXPOSURE OF BISMUTH

Domestic
Risk of exposure are consuming medications that contain bismuth and using of cosmetic products.
Environmental
Bismuth metal is not considered toxic and poses minimum threat to the environment. Generally bismuth compounds have very low solubility but they should be handled with care because there is only limited information on their effects and fate in the environment.
PHARMACOKINETICS OF BISMUTH
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Absorption Only approximately 0.2% of orally administered bismuth is absorbed systematically from the gastrointestinal tract.Minimal absorption of bismuth occurs from bismuth-tin shot embedded in muscles of waterfowl. Gastrointestinal absorption is also relatively poor, with the total absorption of ingested bismuth being about 1%. Then the bismuth which is absorbed is transported in the blood bound to a plasma metallothionein and widely distributes throughout tissues. Bismuth accumulates in kidney, bone (metaphysis), liver, spleen, heart and muscle. With a half-life of months to years, bismuth in bone is very slowly turned over. Protein-bound bismuth also concentrates in the placenta, and can cross the placenta into the amniotic fluid and the fetus. Bismuth is primarily excreted via kidney as this organ contains the highest concentrations of bismuth. However, lesser amounts of bismuth are excreted through saliva, milk and bile.
Distribution and Excretion
Bismuth is primarily excreted via kidney as this organ contains the highest concentrations of bismuth. However, lesser amounts of bismuth are excreted through saliva, milk and bile.Their solubilities are low in the blood, and can be easily removed with urine, showed no carcinogenic, mutagenic or teratogenic effects in long-term tests on animals. Its biological half-life for whole body retention is about 5 days but it can remain in the kidney for years in patients treated with bismuth compounds.
Mechanism of action/ toxicity
Adverse health effects are observed when nephrotoxicity of bismuth has been reported after exposure to pharmaceuticals containing this element. In renal proximal tubule cells, bismuth forms intranuclear inclusion bodies which have been shown by X-ray microanalysis to contain bismuth in situ. It has also been shown to induce the synthesis of the metallothionein (metal-binding protein). It has been found that bismuth produce cell deaths by necrosis rather than apoptosis which is the most likely mechanism being bismuth interaction with the renal tubule cell membrane. However, altered regulation of a number of genes was also observed.
ONSET AND DURATION
The symptoms occur over 26 hours after exposure however in case of lower dose, symptoms may occur over 8 days. The poisoning can be acute or chronic and the metal may enter the body by ingestion, inhalation or absorption through the skin or mucous membranes. Large doses can cause fecal impaction. Bismuth toxicity typically presents subacutely with mental changes of memory loss, psychosis and depression with prominent background of ataxia, tremors, myoclonus and seizures.
FATAL DOSE AND FATAL PERIOD
The fatal dose of bismuth is considered to be 524mg orally every 0.1 to 1 hour upto a maximum of 8doses/day(4192mg/day).Probable oral lethal dose in humans is 0.5 -5g/kg. Intoxication occurs from its use in medicine. The time to peak conc. is typically within one hour. The distribution half life is approximately 1 to 4 hours, and the elimination half life is 5 to 11 days. Urinary bismuth is detectable 3 months after the last dose.
NORMAL/ REFERENCE VALUES
In unexposed individuals the level of Bismuth in blood is usually less than 0.05µg/ml. In acute toxicity the level remains high whereas in case of urine the normal levels ranges from 0-20mmol/l and in toxicity the level ranges from 400mmol/l. 
Chronic
Prolonged overexposure to bismuth may cause chronic health effects. Signs of toxicity may include skin reactions, loss of appetite and weight, fatigue, disturbances in sleep and depression. A bluish or brownish discoloration of the gums may also occur in severe cases due to bismuth deposition in the gums.It may also cause damage to central nervous system, gastrointestinal disturbances and anemia.
CLINICAL APPEARANCES/ SYMPTOMS IN CASE OF BISMUTH POISONING
In case of Bismuth poisoning, clinical appearance/systems will depend on different forms of bismuth and doses taken, which has been discussed as 
One drop of potassium iodide solution
is added to one portion, followed by a drop of acidified aqueous cinchonine solution.
Appearance of orange color is
indicative of the presence of bismuth.
Quantitative Analysis a. UV-Visible Spectroscopy method
Bismuth can be detected quantitatively by using UV-Visible spectrophotometry. Bismuth can form complexed with organic compounds which will give absorbance at specified wavelength. It is sensitive method for analysis of Bismuth and can be used to measure several elements simultaneously. In this technique sample is bombarded with the beam of neutrons which generate a range of radio isotopes and as these radioisotopes decay and emit radiation which can be measured, which is characteristic for a particular element.
MANAGEMENT/ TREATMENT OF BISMUTH POISONING
Without a clear history of exposure of bismuth it is very difficult to make diagnosis of bismuth toxicity. Systemic manifestation like renal failure may not be recognizable for several days even after large overdose of bismuth. In these patients it is necessary to monitor renal and liver function for several days and treat failure conventionally. 
Enhanced Elimination
There is no evidence of enhanced elimination by diuresis (increased or excessive production of urine) or hemodialysis (medical procedure to remove fluid and waste products from the blood and to correct electrolyte imbalances). Several case reports suggests that chelation with unithiol in combination with hemodialysis may increase bismuth elimination from body.
DISCUSSION AND CONCLUSION
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Consumption and production of bismuth compounds are increasing but a little information on the toxic effect and also the effective method in removal of bismuth compounds are available. Bismuth finds its main applications in pharmaceuticals, sprinkler systems, atomic fire alarms, solders, other alloys and even as a catalyst in rubber production. It is also used as pigments for cosmetics, glass and ceramics. Bismuth is a recognized toxic element and is not considered as carcinogenic. However, some of its compounds like Bismuth chloride need to be handled with care due to their corrosiveness. Over exposure to bismuth can lead to the formation of a black deposit on the gingiva. This is known as a bismuth line. Bismuth and its salts lead to kidney damage, although generally to a mild degree. However, large doses can be fatal, although industrially it is considered one of the less toxic heavy metals. Inhalation of bismuth may affect both the liver and kidneys.
Direct contact with bismuth may cause irritation to the eyes and skin. The main organs involved in bismuth poisoning are kidney, liver and bladder. Skin and respiratory irritation can also follow exposure to respective organs. Large concentration of bismuth is contained in kidney and is primarily excreted through this organ while lesser amounts of bismuth are excreted via saliva, milk and bile. Heavy metal poisoning is caused by the accumulation of certain metals like bismuth in the body due to exposure through industrial chemicals inhalation and ingestion. Treatment of heavy metal poisoning includes chelating agents such as Chemet which bind to the metal and are then excreted in your urine, diuretic called mannitol, hemodialysis and other special treatments if kidney failure occurs. The following steps are required for the prevention of Bismuth metal poisoning: 1. Wear masks and protective clothing if working around Bismuth and its compounds. 2. Since many metals accumulate in dust and dirt, keep these out of home as much aspossible. 3. Check for any Bismuth metals listed on the labels of products brought to the home. 4. Use of bismuth products should be avoided by the individuals having blood disorders, hearing problems, gastrointestinal bleeding, peptic ulcer disease, sensitivity to salicylate, or tinnitus "ringing" in the ears. 5. Use of bismuth products may increase the 6. risk of bleeding so caution is advised in people with bleeding disorders or taking drugs that may increase the risk of bleeding. Dosing adjustments may be necessary. 7. Use of bismuth subsalicylate during breastfeeding must be avoided, as it may get absorbed by the infant.
